Navigation Links
Bone marrow-derived stem cells may offer novel therapeutic option for skin disorder
Date:12/4/2008

(WASHINGTON, December 3, 2008) Stem cells derived from bone marrow may serve as a novel therapeutic option to treat a disease called epidermolysis bullosa (EB), a disorder characterized by extraordinarily fragile skin, according to a study prepublished online in Blood, the official journal of the American Society of Hematology.

Epidermolysis bullosa is a disorder characterized by extraordinarily fragile skin and blistering on touch, akin to third degree burns. While the disease is often lethal in the neonatal period, more severe forms of the disease, such as recessive dystrophic EB (referred to as RDEB), can lead to years of painful blistering and mutilating scarring. The condition is caused by significantly reduced collagen type 7 protein (col7) production, a key component of the anchoring fibrils that connect the cutaneous membranes to the dermis of the skin and mucosal tissues in the gastrointestinal tract. A lack of these fibrils means the dermal-epidermal connection is very sensitive, and any action, which can include simple functions such as walking or eating, and the touch of clothing, creates friction between the skin layers that creates blisters and painful sores.

Children with RDEB, who are often referred to as butterfly children because their skin is said to be as sensitive as butterfly wings, develop painful skin and mucosal blistering, mutilating scarring, alopecia (hair loss), and other erosions shortly after birth. As a result of the extreme fragility of the skin and the chronic trauma of friction, RDEB patients often develop squamous cell carcinomas (a form of skin cancer). There is currently no cure for the disease, and palliative care includes complex bandaging, surgical removal of damaged tissue, and nutritional support.

We have been looking into stem cells as viable treatment options for correction of conditions such as epidermolysis bullosa, because they can produce extracellular m
'/>"/>

Contact: Patrick C. Irelan
pirelan@hematology.org
202-292-0253
American Society of Hematology
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Tumors use enzyme to recruit regulatory T-cells and suppress immune response
2. Brain cells work differently than previously thought
3. Embryonic Stem Cells Repair Human Heart
4. Embryonic Human Stem Cells May Help Repair Heart Muscle, Lab Study Shows
5. Circulating fats kill transplanted pancreas cells, study shows
6. Experimental anti-cancer drug made from corn lillies kills brain tumor stem cells
7. Melanoma drug revs immune cells but cancer cells ignore it
8. Scientists explain how insulin secreting cells maintain their glucose sensitivity
9. Embryonic stem cells used to grow cartilage
10. Molecular probe paints cancer cells in living animals, Stanford researchers find
11. USC researcher identifies stem cells in tendons that regenerate tissue in animal model

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...diation dose was equivalent to 113 chest X-rays, s...y News) -- More than half of patients who have abd...ary imaging tests that expose them to extra radiat...CT abdominal and pelvic series were performed on 5... patients were 30 to 50 years of age. The research...
(Date:11/30/2009)... Sponsored by Merck, the unique online and mobile ...n their HIV treatment decisions ,, ARLINGTON, ...( www.thebody.com ), the #1 HIV/AIDS resource onli...d mobile tool offering HIV/AIDS-infected patients ...al data. The tool, created with sponsorship from M...
(Date:11/30/2009)...HAFFHAUSEN, Switzerland, Nov. 30 /PRNewswire-First...day announced that its 2010 annual general meeting...10, 2010 at 3:00 p.m. Central European time at the...02 Zurich, Switzerland. Registered shareholders as...itled to vote at the annual general meeting. Addi...
(Date:11/30/2009)... two years of development and extensive discussion...ality and Efficiency in Health Care (IQWiG) presen... cost and benefit. The Institute can now apply the...rded by the Federal Joint Committee (G-BA). The me... recommendations to the GKV-Spitzenverband [Nation...
(Date:11/30/2009)..., NEW YORK, Nov. 30 Reportlinker...s available in its catalogue: ,, Key Players a...g strategies in ingredients, pharma, food and drin...y-Players-and-Innovative-Start-Ups-in-Nutraceutica...and-drinks.html ,, Nutraceuticals are bioactiv...
Breaking Medicine News(10 mins):Health News:CT Scan Patients May Get Unnecessary Imaging 2Health News:TheBody.com Launches My Health Tracker, Enabling HIV-Positive Patients to Track Lab Results, Medications and Supplements 2Health News:IQWiG presents a method for evaluating the relation between cost and benefit 2Health News:IQWiG presents a method for evaluating the relation between cost and benefit 3Health News:IQWiG presents a method for evaluating the relation between cost and benefit 4Health News:IQWiG presents a method for evaluating the relation between cost and benefit 5Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 2Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 3Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 4Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 5Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 6
... pharmaceutical group Roche announced Wednesday a ...iscovering a contamination in tablets. "Roch...regions all batches of Viracept powder and tablets...ral reports that some batches of Viracept 250 mg t...
...rominent cancer experts receive e-mail and other f...nt for treating prostate cancer. Cancer survivors ...turday to urge the FDA to approve the drug. Contr...ntified. However, it is clear that the doctors pub...
...-lit by synchronized lasers, a nightclub heaving w...ce hit as a pair cavort on stage dressed in the sk... want more," a DJ shouts to the cavernous hall, wh...cal Friday night, but while many of the clubbers h...
...a common childhood disease in Canada, but thought ...the Montreal area again. The public health depart...e they have their shots (vaccine) up to date. ...h. Two shots are recommended. According ...
...ew England Journal of Medicine published results o... trial of rosiglitazone (brand name, Avandia). Th...hough the findings from RECORD (Rosiglitazone Eval...sk of heart failure, this interim analysis did not...
...ORD, Mass., Cynosure, Inc., a leading developer an...thetic treatment systems, today announced the laun...pting (SM) Workstation. The new 10-watt workstatio... the time as the original 6-watt workstation. ...
Other Medicine News:Health News:Cancer Experts Received Threats for Opposing Controversial Drug 2Health News:Drugs Lure Hong Kong Youth Across China Border 2Health News:Drugs Lure Hong Kong Youth Across China Border 3Health News:Measles Outbreak in Canada, Officials Urge Vaccination 2Health News:Patients Advised for Using Rosiglitazone to See Their Doctor - ADA 2Health News:Cynosure Introduces Higher Power Smartlipo(TM) LaserBodySculpting Workstation 2
(Date:11/30/2009)... -- MedPro Imaging, a premium provider of new and ...ading ultrasound solutions including the Mindray M...ion during the company,s debut at the 95th Radiolo...ng held in Chicago November 29 - Dec. 3, 2009. The... products and services in 17 countries, providing ...
(Date:11/30/2009)...re/ -- Minimally-invasive procedures are increasin...ly in oncology, cardiology and women,s health appl...avigation expected to reach $600 million by 2015, ... minimally-invasive procedures, including shorter ...d faster patient throughput. ,, (Logo: http:...
(Date:11/30/2009)...30 Today at the 95th Scientific As...ciety of North America (RSNA), Bayer HealthCare Ph... first patient in an international Phase III clini...lorbetaben (BAY 94-9172) PET imaging in the detect...e a pathological hallmark of Alzheimer,s disease. ...
Breaking Medicine Technology:MedPro Imaging to Showcase Leading New and Refurbished Ultrasound Solutions at RSNA 2Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 2Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 3Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 4Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 5Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimer's Disease 2Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimer's Disease 3Giant Bud Banner Half the Size of Football Field Flies Sunday Protesting Hydroponics Industry Cartel Monopoly that 26apos 3Bs Harming California 26apo 52717 1Giant Bud Banner Half the Size of Football Field Flies Sunday Protesting Hydroponics Industry Cartel Monopoly that 26apos 3Bs Harming California 26apo 52717 2Giant Bud Banner Half the Size of Football Field Flies Sunday Protesting Hydroponics Industry Cartel Monopoly that 26apos 3Bs Harming California 26apo 52717 3Accuray Announces CyberKnife Access Remote Service Product 52715 1Accuray Announces CyberKnife Access Remote Service Product 52715 2Accuray Announces CyberKnife Access Remote Service Product 52715 3Accuray Announces CyberKnife Access Remote Service Product 52715 4Assara Laser Hair Removal Centers 28New York NY 29 Receives 2008 New York Award for Cosmetology 26amp 3B Personal Hygiene Salons by the U S C A 52713 1Assara Laser Hair Removal Centers 28New York NY 29 Receives 2008 New York Award for Cosmetology 26amp 3B Personal Hygiene Salons by the U S C A 52713 2
THORACOPORT™ (Single Use Trocars With Non-conductive Sleeves)
VersaStep™ SHORT Reposable (Reusable Components - Short Length)
VersaStep™ Reposable Powershield™ (Reusable Radiolucent Cannulae - Short Length)
VERSASTEP™ Reposable Sterilization Trays
Medicine Products: